Dr. Rahul Kushwah reports

QSCREEN AI ANNOUNCES STRATEGIC FINANCING TO ADVANCE COMMERCIALIZATION INITIATIVES ACROSS NORTH AMERICA

QScreen AI Inc. has arranged a non-brokered private placement. The company intends to issue up to 10 million units at a price of five cents per unit, for aggregate gross proceeds to the company of up to $500,000.

Each unit will be composed of one common share of the company and one-half of one common share purchase warrant. Each warrant will entitle the holder thereof to purchase one-half common share of the company at a price of 15 cents for a period of 36 months following the closing date of the offering. If, following four months and a day after the closing date, the volume-weighted average price of the common shares on the Canadian Securities Exchange is equal to or greater than 30 cents for any 10 consecutive trading days, the corporation may, upon providing written notice to the holders of warrants, accelerate the expiry date of the warrants to the date that is 30 days following the date of such written notice.

The financing will enable the company to advance structured pilot discussions and operational integration planning with select organizations, building on the momentum from recent Canadian trade mission engagements in Mexico. Proceeds will also support working capital requirements associated with scaling commercialization efforts across enterprise-scale health care, industrial and technology sectors.

The company has received preliminary indications of interest from select investors for participation in the private placement, reflecting the strong market interest in supporting its continuing commercialization initiatives.

About QScreen AI Inc.

QScreen is an emerging provider of rapid health screening and remote patient care solutions globally. The company's Smarthealth AI stations are powered by a proprietary artificial intelligence and use multispectral cameras to analyze physiological data patterns and predict a variety of health issues including 19 physiological vitals, impairment by drugs or alcohol, fatigue, or various mental illnesses. QScreen AI's proprietary remote patient care platform empowers medical professionals with a suite of artificial-intelligence-powered tools to improve patient health outcomes.

We seek Safe Harbor.